20
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Antioxidant BO-653 and human macrophage-mediated LDL oxidation

, , &
Pages 59-71 | Received 02 Jun 1998, Accepted 17 Aug 1998, Published online: 07 Jul 2009
 

Abstract

Oxidation of LDL is now widely accepted to be involved in atherogenesis. The aim of this study was to examine the effect of BO-653, a strong radical scavenger and antioxidant, on oxidation of LDL by human macrophages in vitro. Fifty μg/ml LDL protein was incubated with macrophages in Ham's F10 medium, supplemented with additional Fe2+, for up to 48h. Then the medium was analysed by LDL agarose gel electrophoresis, the thiobarbituric acid assay and gas chromatography. In the absence of added exogenous antioxidants, after 24 h LDL oxidation produced 30.48 nmoles MDA equivalents/mg LDL protein and a relative electrophoretic mobility of 4.74. Linoleic acid (18:2), arachidonic acid (20:4) and cholesterol were depleted and 7β-hydroxycholesterol was generated. BO-653 completely inhibited this cell-mediated oxidation of LDL in concentrations as low as 5 μM, being more effective than either α-tocopherol or probucol, which completely inhibited oxidation at 200 and 80 μM and only partially at 80 and 8 μM, respectively. This inhibition of cell-mediated LDL oxidation was not due to toxicity, as α-tocopherol, probucol and BO-653 were not toxic for the macrophages at the concentrations tested. Eighty μM α-tocopherol, 8 μM probucol and 5 μM BO-653 significantly reduced the toxicity to the oxidising culture caused by LDL oxidation. The results show that in this system BO-653 is a more effective antioxidant than α-tocopherol or probucol.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.